Controlling Health Care Costs Catastrophic Coverage in the Medicare Part D Drug Benefit: Which Beneficiaries Need It and How Much Are They Spending? Issue Briefs / Sep 17, 2020
Controlling Health Care Costs Drug Pricing and Pandemic Preparedness in the 2022 FDA User Fee Reauthorization Process Blog / Jul 23, 2020
Improving Health Care Quality COVID-19 Highlights Problems with Our Generic Supply Chain Blog / May 07, 2020
Achieving Universal Coverage Supreme Court Tells Government to “Honor its Obligations” to ACA Insurers Blog / May 04, 2020
Controlling Health Care Costs The Elijah E. Cummings Lower Drug Costs Now Act: How It Would Work, How It Would Affect Prices, and What the Challenges Are Issue Briefs / Apr 09, 2020
Controlling Health Care Costs Looking Ahead: Policy Options for Addressing High Drug Prices Blog / Jul 30, 2019
Controlling Health Care Costs Market Concentration and Potential Competition in Medicare Advantage Issue Briefs / Feb 14, 2019
Controlling Health Care Costs Bipartisan Bill Would Increase Competition Among Drug Manufacturers and Lower Drug Prices Blog / Jan 29, 2018
Controlling Health Care Costs ACA “Bare Counties”: Policy Options to Ensure Access Must Address Longer-Term Stability and Competition Blog / Sep 14, 2017
Achieving Universal Coverage Turmoil in Individual Private Health Insurance Markets: Welcome to Real Competition Blog / Jul 26, 2016
Controlling Health Care Costs Competition Among Medicare’s Private Health Plans: Does It Really Exist? Issue Briefs / Aug 25, 2015
Controlling Health Care Costs Medicare's Private Plans: Where's the Competition? Infographic / Aug 25, 2015